SandlerResearch

Asia-Pacific In Vitro Diagnostics Market Outlook to 2016 Now Available at SandlerResearch

 

Dallas, TX -- (SBWIRE) -- 11/26/2010 -- SandlerResearch announce Asia-Pacific In Vitro Diagnostics Market Outlook to 2016

Asia-Pacific In Vitro Diagnostics Market Outlook to 2016

GlobalData’s new report, “Asia Pacific In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Asia Pacific In Vitro Diagnostics market – Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories – Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture, and Haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Countries covered include Japan, China, India, and Australia.

- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture, and Haematology.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2002 to 2009, forecast forward for 7 years to 2016.

- 2009 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Asia Pacific In Vitro Diagnostics market.

- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Biomerieux Sa, Beckman Coulter, Bio-Rad Laboratories, Ortho-Clinical Diagnostics, Becton, Dickinson and Company, Sysmex Corporation, Phadia, Qiagen, and Alere.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia Pacific In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents 2

1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What is This Report About? 14
3 Asia-Pacific In Vitro Diagnostics 15
3.1 In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2002-2016 15
3.2 In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), 2002-2016 16
3.3 In Vitro Diagnostics, Asia-Pacific, Company Share (2008-2009) 23
4 In Vitro Diagnostics In Japan 25
4.1 In Vitro Diagnostics, Japan, Overall Revenue ($m), 2002-2016 25
4.2 In Vitro Diagnostics, Japan, Distribution Share (2008-2009) 31
4.2.1 Clinical Chemistry, Japan, Distribution Share (2008-2009) 31
4.2.2 Genetic Testing, Japan, Distribution Share (2008-2009) 31
4.2.3 Haematology, Japan, Distribution Share (2008-2009) 32
4.2.4 Histology and Cytology, Japan, Distribution Share (2008-2009) 32
4.2.5 Immuno Chemistry, Japan, Distribution Share (2008-2009) 33
4.2.6 Infectious Immunology, Japan, Distribution Share (2008-2009) 33
4.2.7 Microbiology Culture, Japan, Distribution Share (2008-2009) 34
4.3 In Vitro Diagnostics, Japan, Company Share (2008-2009) 35
4.3.1 In Vitro Diagnostics, Japan, Company Share (2008-2009) 35
4.3.2 Clinical Chemistry, Japan, Company Share (2008-2009) 37
4.3.3 Genetic Testing, Japan, Company Share (2008-2009) 39
4.3.4 Haematology, Japan, Company Share (2008-2009) 41
4.3.5 Histology and Cytology, Japan, Company Share (2008-2009) 43
4.3.6 Immuno Chemistry, Japan, Company Share (2008-2009) 45
4.3.7 Infectious Immunology, Japan, Company Share (2008-2009) 47
4.3.8 Microbiology Culture, Japan, Company Share (2008-2009) 49
5 In Vitro Diagnostics In China 51
5.1 In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 51
5.2 In Vitro Diagnostics, China, Distribution Share (2008-2009) 57
5.2.1 Clinical Chemistry, China, Distribution Share (2008-2009) 57
5.2.2 Genetic Testing, China, Distribution Share (2008-2009) 57
5.2.3 Haematology, China, Distribution Share (2008-2009) 58
5.2.4 Histology and Cytology, China, Distribution Share (2008-2009) 58
5.2.5 Immuno Chemistry, China, Distribution Share (2008-2009) 59
5.2.6 Infectious Immunology, China, Distribution Share (2008-2009) 59
5.2.7 Microbiology Culture, China, Distribution Share (2008-2009) 60
5.3 In Vitro Diagnostics, China, Company Share (2008-2009) 61
5.3.1 In Vitro Diagnostics, China, Company Share (2008-2009) 61
5.3.2 Clinical Chemistry, China, Company Share (2008-2009) 63
5.3.3 Genetic Testing, China, Company Share (2008-2009) 65
5.3.4 Haematology, China, Company Share (2008-2009) 67
5.3.5 Histology and Cytology, China, Company Share (2008-2009) 69
5.3.6 Immuno Chemistry, China, Company Share (2008-2009) 71
5.3.7 Infectious Immunology, China, Company Share (2008-2009) 73
5.3.8 Microbiology Culture, China, Company Share (2008-2009) 75
6 In Vitro Diagnostics In Australia 77
6.1 In Vitro Diagnostics, Australia, Overall Revenue ($m), 2002-2016 77
6.2 In Vitro Diagnostics, Australia, Distribution Share (2008-2009) 83
6.2.1 Clinical Chemistry, Australia, Distribution Share (2008-2009) 83
6.2.2 Genetic Testing, Australia, Distribution Share (2008-2009) 83
6.2.3 Haematology, Australia, Distribution Share (2008-2009) 84
6.2.4 Histology and Cytology, Australia, Distribution Share (2008-2009) 84
6.2.5 Immuno Chemistry, Australia, Distribution Share (2008-2009) 85
6.2.6 Infectious Immunology, Australia, Distribution Share (2008-2009) 85
6.2.7 Microbiology Culture, Australia, Distribution Share (2008-2009) 86
6.3 In Vitro Diagnostics, Australia, Company Share (2008-2009) 87
6.3.1 In Vitro Diagnostics, Australia, Company Share (2008-2009) 87
6.3.2 Clinical Chemistry, Australia, Company Share (2008-2009) 89
6.3.3 Genetic Testing, Australia, Company Share (2008-2009) 91
6.3.4 Haematology, Australia, Company Share (2008-2009) 93
6.3.5 Histology and Cytology, Australia, Company Share (2008-2009) 95
6.3.6 Immuno Chemistry, Australia, Company Share (2008-2009) 96
6.3.7 Infectious Immunology, Australia, Company Share (2008-2009) 98
6.3.8 Microbiology Culture, Australia, Company Share (2008-2009) 100
7 In Vitro Diagnostics In India 102
7.1 In Vitro Diagnostics, India, Overall Revenue ($m), 2002-2016 102
7.2 In Vitro Diagnostics, India, Distribution Share (2008-2009) 108
7.2.1 Clinical Chemistry, India, Distribution Share (2008-2009) 108
7.2.2 Genetic Testing, India, Distribution Share (2008-2009) 108
7.2.3 Haematology, India, Distribution Share (2008-2009) 109
7.2.4 Histology And Cytology, India, Distribution Share (2008-2009) 109
7.2.5 Immuno Chemistry, India, Distribution Share (2008-2009) 110
7.2.6 Infectious Immunology, India, Distribution Share (2008-2009) 110
7.2.7 Microbiology Culture, India, Distribution Share (2008-2009) 111
7.3 In Vitro Diagnostics, India, Company Share (2008-2009) 112
7.3.1 In Vitro Diagnostics, India, Company Share (2008-2009) 112
7.3.2 Clinical Chemistry, India, Company Share (2008-2009) 114
7.3.3 Genetic Testing, India, Company Share (2008-2009) 116
7.3.4 Haematology, India, Company Share (2008-2009) 118
7.3.5 Histology and Cytology, India, Company Share (2008-2009) 120
7.3.6 Immuno Chemistry, India, Company Share (2008-2009) 122
7.3.7 Infectious Immunology, India, Company Share (2008-2009) 124
7.3.8 Microbiology Culture, India, Company Share (2008-2009) 126
8 Overview of Key Companies in Asia-Pacific In Vitro Diagnostics Market 128
8.1 F. Hoffmann-La Roche Ltd. 128
8.1.1 Company Overview 128
8.1.2 Share in the Asia-Pacific In Vitro Diagnostics Market 128
8.2 Siemens Healthcare 129
8.2.1 Company Overview 129
8.2.2 Share in the Asia-Pacific In Vitro Diagnostics Market 129
8.3 Abbott Laboratories 130
8.3.1 Company Overview 130
8.3.2 Share in the Asia-Pacific In Vitro Diagnostics Market 130
8.4 Beckman Coulter, Inc. 131
8.4.1 Company Overview 131
8.4.2 Share in the Asia-Pacific In Vitro Diagnostics Market 131
8.5 Sysmex Corporation 132
8.5.1 Company Overview 132
8.5.2 Share in the Asia-Pacific In Vitro Diagnostics Market 132
8.6 Becton, Dickinson and Company 133
8.6.1 Company Overview 133
8.6.2 Share in the Asia-Pacific In Vitro Diagnostics Market 133
8.7 Ortho-Clinical Diagnostics Inc. 134
8.7.1 Company Overview 134
8.8 bioMerieux S.A. 134
8.8.1 Company Overview 134
8.9 Alere Inc 134
8.9.1 Company Overview 134
8.10 Bio-Rad Laboratories, Inc. 135
8.10.1 Company Overview 135
8.11 Qiagen N.V. 135
8.11.1 Company Overview 135
8.12 Gen-Probe Incorporated 135
8.12.1 Company Overview 135
8.13 Hologic, Inc. 136
8.13.1 Company Overview 136
8.14 Phadia AB 136
8.14.1 Company Overview 136
8.15 Shanghai Kehua Bio-engineering Co., Ltd. 137
8.15.1 Company Overview 137
8.16 Mindray Medical International Limited 137
8.16.1 Company Overview 137
8.17 Transasia Bio-Medicals Ltd. 138
8.17.1 Company Overview 138
8.18 Trivitron Group of Companies 138
8.18.1 Company Overview 138
8.19 Span Diagnostics Ltd. 138
8.19.1 Company Overview 138
8.20 J.Mitra & Co. Pvt Ltd 139
8.20.1 Company Overview 139
9 Financial Deals Landscape 140
9.1 Acquisition 140
9.1.1 bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 140
9.1.2 Inverness Medical Innovations Acquires 78.13% Stake In Standard Diagnostics 141
9.2 Partnerships 143
9.2.1 BIOCIUS Life Sciences Enters Into Distribution Agreement With Wako Pure Chemical Industries 143
9.2.2 QIAGEN Enters Into Distribution Agreement With Celera 144
9.2.3 Sequenom Enters Into Licensing Agreement With Optherion 145
9.2.4 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 146
9.2.5 Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech 147
9.2.6 Epithelix Enters Into Distribution Agreement With Iwaki & Co. 148
9.2.7 Rubicon Genomics Enters Into Agreement With ZyGEM 149
9.2.8 TriLink BioTechnologies Enters Into Distribution Agreement With Nacalai USA 150
9.2.9 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 151
9.2.10 Anteo Diagnostics Enters Into Licensing Agreement With Bangs Laboratories 152
9.2.11 Response Genetics Enters Into Distribution Agreement With Genetic Technologies 153
9.2.12 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 154
10 Recent Developments 155
10.1 Strategy and Business Planning 155
10.1.1 Sep 30, 2010: Circadian Partners with CCHMC To Develop Blood Test To Diagnose Potentially Fatal Lung Disease 155
10.1.2 Aug 18, 2010: Thermo Fisher Scientific Opens Technology Center In Shanghai 155
10.1.3 Apr 12, 2010: Olympus Establishes New Company In India 156
10.1.4 Feb 17, 2010: PerkinElmer Launches New Health Screening Lab In India 156
10.2 Legal and Regulatory 156
10.2.1 May 26, 2010: Trivitron Signs Pact With IIT Madras To Set Up New Center 156
10.2.2 Mar 08, 2010: Chinmax Medical Systems Files Complaint In China Against Inverness Medical Beijing Over Distribution Rights 157
10.3 Government and Public Interest 157
10.3.1 Jul 29, 2010: New Lab Test Could Identify Imatinib Resistance: Hokkaido University Graduate School Of Medicine 157
10.3.2 Jul 07, 2010: NZMA Supports Changes To Lab Test Charges 158
10.3.3 Jun 29, 2010: CSL Receives "Untitled Letter" From FDA 158
10.3.4 May 27, 2010: China Sky One Medical Receives GMP Re-Certification 159
10.3.5 Apr 27, 2010: New Diagnostic Kit To Improve Health Outcomes For HIV Patients 159
10.3.6 Mar 25, 2010: New Test Takes Guesswork Out Of Diagnosing Early Stage Alzheimer's Disease 160
10.3.7 Mar 25, 2010: New Test Helps Diagnose And Treat Early Stage Alzheimer's Disease 160
10.4 Product News 161
10.4.1 Aug 23, 2010: Life Technologies Launches 3500 Dx Series Genetic Analyzer In Asia Pacific 161
10.4.2 Jul 26, 2010: Seegene Announces SeePrep And SeeCycler To Create Complete Molecular Diagnostic System 161
10.4.3 Jul 20, 2010: Seegene Launches Magicplex Sepsis Test 162
10.4.4 Jul 01, 2010: Diagnostic Hybrids Receives SFDA Approval For D3 Ultra DFA Respiratory Virus Identification Kit 163
10.4.5 Jun 29, 2010: China Medical Technologies Announces Recent Publication Of Study On SPR System 163
10.4.6 Jun 29, 2010: Samsung Electronics Launches Ultra-Fast Blood-Testing Device 163
10.4.7 Jun 17, 2010: WaferGen Announces Kyoto University To Use SmartChip Real-Time PCR System To Identify And Compare Biomarkers To Advance Regenerative Tissue Research 163
10.4.8 Jun 09, 2010: China Medical Technologies Receives SFDA Approval For Its SPR-Based HPV-DNA Chip 164
10.4.9 Jun 08, 2010: WaferGen Signs Exclusive Distribution Agreement For SmartChip Real-Time PCR System In Japan 164
10.4.10 Apr 14, 2010: HairDX Forms Alliance With GBIL To Distribute HairDX Genetic Hair Loss Tests In Hong Kong And Singapore 165
10.4.11 Apr 05, 2010: PinPointe Launches PinPointe FootLaser Treatment In Australia 165
10.4.12 Mar 10, 2010: WaferGen Announces Shipment Of First SmartChip Real-Time PCR System Following CE Mark Approval 166
10.4.13 Jan 28, 2010: Biomagnetics Diagnostics Initiates Clinical Trial For Integrated Optical Biosensor To Detect Malaria And Tuberculosis 167
10.4.14 Jan 22, 2010: Genera Biosystems Announces TGA Approval For PapType HPV Detection And Genotyping Test 168
10.4.15 Jan 11, 2010: Seegene Receives Health Canada License For Seeplex Diarrhea-V ACE Detection Test 168
11 Appendix 170
11.1 Definitions of Markets Covered in the Report 171
11.1.1 In Vitro Diagnostics 171
11.2 Research Methodology 172
11.3 Secondary Research 172
11.4 Primary Research 173
11.5 Models 173
11.6 Forecasts 174
11.7 Expert Panels 174
11.8 GlobalData Consulting 174
11.9 Currency Conversion 175
11.10 Contact Us 175
11.11 Disclaimer 175

ABBREVIATIONS

Browse all : Medical Devices
http://www.sandlerresearch.org/market-research/medical-devices/

Browse all : GlobalData
http://www.sandlerresearch.org/publishers/globaldata/

Browse all : Newly Published
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports :

Worldwide Market for In Vitro Diagnostic Tests, 7th Edition
http://www.sandlerresearch.org/reports/26641-worldwide-market-for-in-vitro-diagnostic-tests-7th-edition-the.html

In Vitro Diagnostics Market - A Hotspot For Venture Capital Funding
http://www.sandlerresearch.org/reports/14586-in-vitro-diagnostics-market-a-hotspot-for-venture-capital-fundi.html

Meat market data in Asia Pacific to 2014
http://www.sandlerresearch.org/reports/40919-meat-market-data-in-asia-pacific-to-2014.html

Asia Pacific Market for Bone Graft Substitutes and Other Biomaterials 2009 (3 Countries)
http://www.sandlerresearch.org/reports/18580-asia-pacific-market-for-bone-graft-substitutes-and-other-biomater.html

Asia Pacific Markets for Dental Implants and Final Abutments
http://www.sandlerresearch.org/reports/25342-asia-pacific-markets-for-dental-implants-and-final-abutments.html

About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.

Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.

We also provide 24/7 online and offline support to our customers

Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/

Original Source : Asia Pacific Vitro Diagnostics Market
http://www.sandlerresearch.org/reports/41253-asia-pacific-in-vitro-diagnostics-market-outlook-to-2016.html

Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html

Browse complete Report at : Asia-Pacific In Vitro Diagnostics Market Outlook to 2016
http://www.sandlerresearch.org/reports/41253-asia-pacific-in-vitro-diagnostics-market-outlook-to-2016.html